D1 and D2 dopamine agonist synergism: separate sites of action?
- 31 August 1987
- journal article
- editorial
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 8 (8), 295-299
- https://doi.org/10.1016/0165-6147(87)90121-0
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- GABA‐mimetic drugs enhance apomorphine‐induced contralateral turning in rats with unilateral nigrostriatal dopamine denervation: Implications for the therapy of Parkinson's diseaseAnnals of Neurology, 1987
- The D1 dopamine receptor: new perspectivesTrends in Pharmacological Sciences, 1986
- Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the ratNeuroscience Letters, 1986
- Selective D2 dopamine receptor agonists prevent catalepsy induced by SCH 23390, a selective D1 antagonistLife Sciences, 1985
- The Classification of Dopamine Receptors: Relationship to Radioligand BindingAnnual Review of Neuroscience, 1983
- Dopamine modulates cholecystokinin release in neostriatumNature, 1983
- Further evidence for the involvement of D2, but not D1 dopamine receptors in dopaminergic control of striatal cholinergic transmissionLife Sciences, 1982
- Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatumNature, 1981
- Dendritic release of dopamine in the substantia nigraNature, 1981
- Release of dopamine from dendrites in rat substantia nigraNature, 1976